Large Volume Wearable Injectors Market Growth Analysis: Opportunities & Forecasts
According to a newly published market research report by 24LifeSciences, global large volume wearable injectors market is valued at USD 1.83 billion in 2026 and is projected to reach USD 15.17 billion by 2034, growing at a compound annual growth rate (CAGR) of 36.2% during the forecast period.
Large volume wearable injectors (LVPIs), sometimes referred to as bolus injectors or on-body delivery systems, are advanced medical devices engineered to administer subcutaneous injections of high-volume drug formulations, typically exceeding 2 ml. These systems are designed to be discreet, portable, and patient-friendly, allowing for the self-administration of complex biologics and other therapies over extended periods, from several minutes to hours, outside of a clinical environment. Their primary value lies in enhancing patient adherence, improving quality of life, and reducing the burden on healthcare facilities by enabling convenient home-based care for chronic conditions.
Download a Free Sample Report (PDF): https://www.24lifesciences.com..../download-sample/726
